Müller Daniel A, Beltrami Giovanni, Scoccianti Guido, Cuomo Pierluigi, Capanna Rodolfo
Department of Orthopaedic Surgery, University Hospital Balgrist, Zurich, Switzerland.
Department of Orthopaedic Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Injury. 2016 Oct;47 Suppl 4:S124-S130. doi: 10.1016/j.injury.2016.07.043. Epub 2016 Aug 5.
Modular megaprosthesis (MP) and allograft-prosthetic composite (APC) are the most commonly used reconstructions for large bone defects of the proximal tibia. The primary objective of this study was to compare the two different techniques in terms of failures and functional results. A total of 42 consecutive patients with a mean age of 39.6 years (range 15-81 years) who underwent a reconstruction of the proximal tibia between 2001 and 2012 were included. Twenty-three patients were given an MP, and 19 patients received an APC. There were nine reconstruction failures after an average follow-up of 62 months: five in the MP group and four in the APC group (p=0.957). The 10-year implant survival rate was 78.8% for the MP and 93.7% for the APC (p=0.224). There were no relevant differences between the two groups in functional results. Both MP and APC are valid and satisfactory reconstructive options for massive bone defects in the proximal tibia. In high-demanding patients with no further risk factors, an APC should be considered to provide the best possible functional result for the extensor mechanism.
模块化大假体(MP)和同种异体骨-假体复合物(APC)是胫骨近端大骨缺损最常用的重建方法。本研究的主要目的是比较这两种不同技术在失败率和功能结果方面的差异。纳入了2001年至2012年间连续接受胫骨近端重建的42例患者,平均年龄39.6岁(范围15 - 81岁)。23例患者接受了MP,19例患者接受了APC。平均随访62个月后有9例重建失败:MP组5例,APC组4例(p = 0.957)。MP的10年植入物生存率为78.8%,APC为93.7%(p = 0.224)。两组在功能结果方面无显著差异。MP和APC都是胫骨近端大块骨缺损有效的、令人满意的重建选择。对于没有进一步危险因素的高要求患者,应考虑使用APC以提供伸膝机制最佳的功能结果。